Thymol Attenuates Klebsiella pneumoniae Induced Lung Injury via Modulation of Peroxidase‐Driven Oxidative Stress and Host–Pathogen Interactions: In Vivo and In Silico Insights
- 23 June 2026
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 40 (7) , e70997
Abstract
Klebsiella pneumoniae pneumonia drives excessive inflammatory and oxidative responses that culminate in acute lung injury (ALI) and impaired bacterial clearance. Effective therapies capable of restoring host–pathogen balance remain limited, particularly in the context of multidrug‐resistant strains. This study investigated the therapeutic efficacy of thymol in a murine model of K. pneumoniae ‐induced ALI. Oral thymol (5–20 mg/kg) markedly reduced lung injury, suppressed leukocyte infiltration, improved pulmonary histoarchitecture, and significantly enhanced bacterial clearance. Thymol reshaped systemic and local immune responses by decreasing tumor necrosis factor‐α (TNF‐α) and C‐reactive protein (CRP), increasing interleukin‐10 (IL‐10), and limiting macrophage and granulocyte recruitment. Mechanistically, thymol attenuated heme peroxidase‐driven oxidative stress, as evidenced by reduced myeloperoxidase (MPO) and eosinophil peroxidase (EPO) activities, decreased malondialdehyde (MDA), hydrogen peroxide (H 2 O 2 ), and nitric oxide (NO), along with restoration of catalase activity and glutathione levels. Complementary in silico docking predicted stable interactions of thymol with MPO and EPO, as well as essential bacterial metabolic enzymes, including deoxy‐D‐xylulose‐5‐phosphate synthase (DXS), acetolactate synthase (ALS), and dihydrodipicolinate synthase (DHDPS). Collectively, these findings suggest that thymol may act as a multi‐target bioactive compound capable of modulating host inflammatory and redox pathways while potentially impairing bacterial metabolic fitness, thereby mitigating pneumonia‐associated ALI.Keywords
This publication has 33 references indexed in Scilit:
- Risk factors, outcomes, and epidemiological and etiological study of hospitalized COVID-19 patients with bacterial co-infection and secondary infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2024
- 1-deoxy-D-xylulose-5-phosphate synthase from Pseudomonas aeruginosa and Klebsiella pneumoniae reveals conformational changes upon cofactor bindingJournal of Biological Chemistry, 2023
- Role of myeloperoxidase and oxidant formation in the extracellular environment in inflammation-induced tissue damageFree Radical Biology and Medicine, 2021
- Priming of intestinal cytoprotective genes and antioxidant capacity by dietary phytogenic inclusion in broilersAnimal Nutrition, 2020
- Thymol reduces acetic acid-induced inflammatory response through inhibition of NF-kB signaling pathway in rat colon tissueInflammopharmacology, 2019
- Thymol improves high-fat diet-induced cognitive deficits in mice via ameliorating brain insulin resistance and upregulating NRF2/HO-1 pathwayMetabolic Brain Disease, 2016
- Quantitative assay for acute intestinal inflammation based on myeloperoxidase activityGastroenterology, 1984
- A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in cultureJournal of Immunological Methods, 1980
- Assay for lipid peroxides in animal tissues by thiobarbituric acid reactionAnalytical Biochemistry, 1979
- Activity and stability of catalase in blood and tissues of normal and acatalasemic miceBiochemical Genetics, 1968